PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
9430443-5	1997	Throughout pregnancy, the stimulatory effect of CCK was enhanced by prior administration of norBNI.	norbinaltorphimine	92-98	cholecystokinin	Rattus norvegicus	48-51	
9430443-7	1997	However, in late pregnancy, between days 17 and 20, there was a significant reduction in the efficacy of norBNI in potentiating the oxytocin release in response to CCK, compared to its efficacy either in non-pregnant rats or in rats between days 8 and 13 of pregnancy.	norbinaltorphimine	105-111	cholecystokinin	Rattus norvegicus	164-167	
7653564-8	1995	Devazepide (1 microgram/kg), naloxone (0.1 mg/kg), and nor-binaltorphimine (nor-BNI; 10 mg/kg) reversed the blocking effect of CCK-8, whereas PD-135,158 (0.1 microgram/kg) and naltrindole (1 mg/kg) have no effect.	norbinaltorphimine	55-74	cholecystokinin	Rattus norvegicus	127-130	
7653564-8	1995	Devazepide (1 microgram/kg), naloxone (0.1 mg/kg), and nor-binaltorphimine (nor-BNI; 10 mg/kg) reversed the blocking effect of CCK-8, whereas PD-135,158 (0.1 microgram/kg) and naltrindole (1 mg/kg) have no effect.	norbinaltorphimine	76-83	cholecystokinin	Rattus norvegicus	127-130